AgingResearch.NewsJoin free
medRxiv

Heart, kidney and metabolic burden centers on later stages

Stages 3–4 included 15.8% of US adults but accounted for 76% of estimated years lost to premature death attributed to cardiovascular-kidney-metabolic syndrome.

Paper by X. Wang, Y. Qiao, H. Sun, +2 more authorsT. Zhang
A damaged heart and kidney sit beneath a small group of dark blue-green figures, while a larger gray group surrounds a smaller, intact heart.

Our read

Populations
Studied:
Preprint: cross-sectional study of US adults
What changed:
Stages 3–4 included 15.8% of adults but accounted for 76% of years lost to premature death attributed to the syndrome
The catch:
Mortality estimates used 1999–2018 data for surveys extending through 2023
Why it’s aging research:
It bears on staying healthy in midlife and later life.

Editor of record: Boris Djordjevic · AgingResearch.News

Paper
Follow @agingbrief

US adults in nine National Health and Nutrition Examination Survey cycles from 2005–2023 were classified into five stages of cardiovascular-kidney-metabolic syndrome in a pooled observational analysis. This system groups linked problems involving the heart, kidneys and the body’s use and storage of energy.

For 2021–2023, the authors estimated an annual burden of 20.0 million disability-adjusted life years—a measure combining years lived with disability and years lost to premature death. Stages 3–4 accounted for 76% of premature-death years attributed to the syndrome. Meanwhile, the population shifted toward an earlier stage: from 2006 to 2016, the share in stage 0 fell 2.3% per year, while the share in stage 1 rose 3.1% per year. Adjusted mortality did not differ between stages 1 and 0.

Why it matters

For heart disease prevention as people age, the authors argued that allocating resources by lost healthy years would systematically underfund early-stage prevention.

Caveats

Burden estimates used disability weights and mortality data from 1999–2018, while surveys extended through 2023; the analysis did not test prevention funding decisions. The report is a preprint and has not been peer-reviewed.

Where the evidence stands

Physical inactivity

Humans: replicated by independent labs. Mice: a single group. Cells and worms or flies: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 223 independent labs in 56 countries
  • 8 findings against
  • Funders: National Institute on Aging and others
  • 7 of 346 findings with company ties

Smoking

Humans: replicated by independent labs. Cells and mice: a single group. Worms or flies: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 823 independent labs in 93 countries
  • 121 findings against
  • Funders: National Institutes of Health and others
  • 135 of 2,008 findings with company ties

Comments

Be the first to comment.

More on Cardiovascular-kidney-metabolic syndrome